These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33138378)

  • 1. Computational Analysis of Alzheimer Amyloid Plaque Composition in 2D- and Elastically Reconstructed 3D-MALDI MS Images.
    Enzlein T; Cordes J; Munteanu B; Michno W; Serneels L; De Strooper B; Hanrieder J; Wolf I; Chávez-Gutiérrez L; Hopf C
    Anal Chem; 2020 Nov; 92(21):14484-14493. PubMed ID: 33138378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry.
    Kaya I; Zetterberg H; Blennow K; Hanrieder J
    ACS Chem Neurosci; 2018 Jul; 9(7):1802-1817. PubMed ID: 29648443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass Spectrometry Imaging in Alzheimer's Disease.
    Ikegawa M; Kakuda N; Miyasaka T; Toyama Y; Nirasawa T; Minta K; Hanrieder J
    Brain Connect; 2023 Aug; 13(6):319-333. PubMed ID: 36905365
    [No Abstract]   [Full Text] [Related]  

  • 4. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural amyloid plaque polymorphism is associated with distinct lipid accumulations revealed by trapped ion mobility mass spectrometry imaging.
    Michno W; Wehrli PM; Koutarapu S; Marsching C; Minta K; Ge J; Meyer SW; Zetterberg H; Blennow K; Henkel C; Oetjen J; Hopf C; Hanrieder J
    J Neurochem; 2022 Feb; 160(4):482-498. PubMed ID: 34882796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
    Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
    J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Trimodal MALDI Imaging Mass Spectrometry (IMS3) at 10 μm Reveals Spatial Lipid and Peptide Correlates Implicated in Aβ Plaque Pathology in Alzheimer's Disease.
    Kaya I; Brinet D; Michno W; Başkurt M; Zetterberg H; Blenow K; Hanrieder J
    ACS Chem Neurosci; 2017 Dec; 8(12):2778-2790. PubMed ID: 28925253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetramodal Chemical Imaging Delineates the Lipid-Amyloid Peptide Interplay at Single Plaques in Transgenic Alzheimer's Disease Models.
    Ge J; Koutarapu S; Jha D; Dulewicz M; Zetterberg H; Blennow K; Hanrieder J
    Anal Chem; 2023 Mar; 95(10):4692-4702. PubMed ID: 36856542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice.
    Kaya I; Jennische E; Lange S; Tarik Baykal A; Malmberg P; Fletcher JS
    J Neurochem; 2020 Jul; 154(1):84-98. PubMed ID: 32141089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2D and 3D MALDI-imaging: conceptual strategies for visualization and data mining.
    Thiele H; Heldmann S; Trede D; Strehlow J; Wirtz S; Dreher W; Berger J; Oetjen J; Kobarg JH; Fischer B; Maass P
    Biochim Biophys Acta; 2014 Jan; 1844(1 Pt A):117-37. PubMed ID: 23467008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
    Yang J; Wadghiri YZ; Hoang DM; Tsui W; Sun Y; Chung E; Li Y; Wang A; de Leon M; Wisniewski T
    Neuroimage; 2011 Apr; 55(4):1600-9. PubMed ID: 21255656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology.
    Michno W; Wehrli PM; Zetterberg H; Blennow K; Hanrieder J
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):458-467. PubMed ID: 30273679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial Lipidomics Reveals Region and Long Chain Base Specific Accumulations of Monosialogangliosides in Amyloid Plaques in Familial Alzheimer's Disease Mice (5xFAD) Brain.
    Kaya I; Jennische E; Dunevall J; Lange S; Ewing AG; Malmberg P; Baykal AT; Fletcher JS
    ACS Chem Neurosci; 2020 Jan; 11(1):14-24. PubMed ID: 31774647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal Chemical Imaging of Amyloid Plaque Polymorphism Reveals Aβ Aggregation Dependent Anionic Lipid Accumulations and Metabolism.
    Michno W; Kaya I; Nyström S; Guerard L; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    Anal Chem; 2018 Jul; 90(13):8130-8138. PubMed ID: 29856605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser-Induced In-Source Decay Applied to the Determination of Amyloid-Beta in Alzheimer's Brains.
    Kelley AR; Perry G; Castellani RJ; Bach SB
    ACS Chem Neurosci; 2016 Mar; 7(3):261-8. PubMed ID: 26720297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-registration of MALDI-MSI and histology demonstrates gangliosides co-localize with amyloid beta plaques in Alzheimer's disease.
    Ollen-Bittle N; Pejhan S; Pasternak SH; Keene CD; Zhang Q; Whitehead SN
    Acta Neuropathol; 2024 Jun; 147(1):105. PubMed ID: 38896306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical signatures delineate heterogeneous amyloid plaque populations across the Alzheimer's disease spectrum.
    Koutarapu S; Ge J; Dulewicz M; Srikrishna M; Szadziewska A; Wood J; Blennow K; Zetterberg H; Michno W; Ryan NS; Lashley T; Savas J; Schöll M; Hanrieder J
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DeepS: Accelerating 3D Mass Spectrometry Imaging via a Deep Neural Network.
    Li D; Qian Y; Yao H; Yu W; Ma X
    Anal Chem; 2023 Jul; 95(29):10879-10886. PubMed ID: 37427961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MALDI mass spectrometric imaging of biological tissue sections.
    Rohner TC; Staab D; Stoeckli M
    Mech Ageing Dev; 2005 Jan; 126(1):177-85. PubMed ID: 15610777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.